Intrexon Corp (XON.N)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|64||2009||Chairman of the Board, Chief Executive Officer|
|51||2016||Founder, Chief Science Officer|
|53||2007||Chief Financial Officer|
|2017||Chief Operating Officer|
|56||2016||Senior Vice President - Finance|
- BRIEF-Exemplar Genetics Rare Neurological Disease Model Cleared By FDA For Commercial Research Use
- BRIEF-Actobio Therapeutics Greenlighted By FDA To Commence A Phase Ib/Iia Trial With AG019
- BRIEF-Intrexon Corp Q4 Loss Per Share $0.23
- BRIEF-Fibrocell Announces FDA Allowance To Initiate Pediatric Enrollment In Phase 1/2 Clinical Trial Of Fcx-007
- BRIEF-Intrexon Prices Public Offering Of Common Stock